2-(2-Amino-2-methylpropoxy)-3,5-dichloropyridine hydrochloride

Catalog No.: 
ACBLIV106
CAS No.: 
1423025-60-8
Molecular Formula: 
C9H13Cl3N2O
Molecular Weight: 
271.58
2-(2-Amino-2-methylpropoxy)-3,5-dichloropyridine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$251.00InquiryInquiry
100mg98%$365.00InquiryInquiry
250mg98%$514.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(2-Amino-2-methylpropoxy)-3,5-dichloropyridine hydrochloride
IUPAC Name1-((3,5-dichloropyridin-2-yl)oxy)-2-methylpropan-2-amine hydrochloride
MDL No.MFCD22421838
Molecular FormulaC9H13Cl3N2O
Molecular Weight271.58
SMILESClC1=CN=C(OCC(C)(N)C)C(Cl)=C1.[H]Cl
InChI KeyUPXUJKIPNGGZBA-UHFFFAOYSA-N
Synonym2-(2-amino-2-methylpropoxy)-3,5-dichloropyridine hydrochloride
CAS No.1423025-60-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACBLIV106 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWYET172 route compound structure diagram
    ACWYET1723207-12-3In Stock
  2. Plus
  3. ACHWNA125 route compound structure diagram
    ACHWNA12516063-70-0In Stock
  4. Then
  5. ACBLIV106 route product structure diagram
    ACBLIV1061423025-60-8
Inquiry

2. ACBLIV106 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBLIV106 route product structure diagram
    ACBLIV1061423025-60-8
Inquiry

3. ACBLIV106 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBLIV106 route product structure diagram
    ACBLIV1061423025-60-8
Inquiry

Comments (0)